GSK PLC LS-,3125GSK PLC LS-,3125GSK PLC LS-,3125

GSK PLC LS-,3125

No trades
See on Supercharts

Price target

21.410.000.00%
The 16 analysts offering 1 year price forecasts for GS71 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 21 analysts giving stock ratings to GS71 in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


GS71 EPS for the last quarter is 0.60 EUR despite the estimation of 0.53 EUR. In the next quarter EPS is expected to reach 0.25 EUR. Track more of GSK PLC LS-,3125 financials and stay on top of what is up with the company.
In the next quarter GSK PLC LS-,3125 revenue is expected to reach ‪9.32 B‬ EUR. Check out GSK PLC LS-,3125 revenue and earnings and make informed decisions.
According to analysts, GS71 price target is 21.41 EUR with a max estimate of 31.09 EUR and a min estimate of 16.92 EUR. Check if this forecast comes true in a year, meanwhile watch GSK PLC LS-,3125 stock price chart and keep track of the current situation with GS71 news and stock market news.
We've gathered opinions of 21 analysts rating GS71 stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.